COVID-19 and Vaccination Strategies in Global Health
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "COVID-19 Vaccines and Vaccination".
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 31366
Special Issue Editor
Special Issue Information
Dear Colleagues,
We have faced challenging times since the beginning of the COVID-19 pandemic. It has affected us all in an unprecedented way, pushing medical authorities, pharmaceutical companies, scientists, patients, and their relatives to find and test solutions which could limit the spread of the Sars-Cov-2 virus or its consequences on our health and on our lives.
As we all know, vaccines have played a major role, both in the scientific debate and in the attempt to contain the pandemic. The year 2022, the third year since the start of the pandemic, has provided an opportunity to update what we know, revise what we thought, and envisage what can be done further to manage pandemics such COVID-19 and eventually prevent future ones.
I therefore invite you all to contribute to this Special Issue of Vaccines on ‘COVID-19 and Vaccination Strategies in Global Health’ with original research articles, reports, and reviews. The scope of this Special Issue is purposefully wide, in order to tackle different points of view: immunology, infectiology, epidemiology, public health, primary care, and medical statistics.
Dr. Davide Barbieri
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- COVID-19
- vaccination
- vaccination strategies
- global health
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.